New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Molecule Holdings Inc.
EVRRF
Shape
US Flag

PNK

Unprofitable

Unprofitable

244455

Drug Manufacturers - Specialty & Generic

Next Earning date - 27 Dec 2024

244455

Drug Manufacturers - Specialty & Generic

Next Earning date - 27 Dec 2024

0.00USD
0.00 ( 0.00%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

100%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

39%

Quote Panel

Shape
Updated October 27, 2024
1W 0.00 % 1M 0.00 % 3M 0.00 % 1Y -39.02 %

Key Metrics

Shape
  • Market Cap

    244455


  • Shares Outstanding

    97.78M


  • Share in Float

    88.32M


  • Dividende

    0


  • Earning Date

    27 Dec 2024


  • Price Target

    0.0025


  • Average Volume


  • Beta

    -0.705


  • Range

    0.002-0.0041


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.molecule.ca


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.37x

P/S Ratio

-0.06x

P/B Ratio

-1.0

Debt/Equity

-161.6%

Net Margin

$-0.0

EPS

How EVRRF compares to sector?

P/E Ratio

Relative Strength

Shape

EVRRF

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

No Data Available

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q2.21

arrow
arrow

N/A

-0.02
vs NA

Q3.21

arrow
arrow

N/A

-0.01
vs 0.02

Q4.21

arrow
arrow

N/A

-0.01
vs -0.03

Q1.22

arrow
arrow

N/A

-0.01
vs -0.01

Q2.22

arrow
arrow

N/A

-0.01
vs -0.02

Q3.22

arrow
arrow

N/A

-0.01
vs -0.01

Q4.22

arrow
arrow

N/A

NA
vs -0.01

Q1.23

arrow
arrow

N/A

-0.01
vs -0.01

Q2.23

arrow
arrow

N/A

-0.00
vs -0.01

Q3.23

arrow
arrow

N/A

-0.01
vs -0.01

Sales GrowthShape

status-upYoY

Current

Estimates

Q2.21

arrow
arrow

NA

68.5K  vs NA

Q3.21

arrow
arrow

NA

204.1K  vs NA

Q4.21

arrow
arrow

NA

131.9K  vs NA

Q1.22

arrow
arrow

NA

204.5K  vs NA

Q2.22

arrow
arrow

+403%

345K  vs 68.5K

Q3.22

arrow
arrow

+190%

592.1K  vs 204.1K

Q4.22

arrow
arrow

+182%

371.8K  vs 131.9K

Q1.23

arrow
arrow

+44%

294K  vs 204.5K

Q2.23

arrow
arrow

-64%

123.1K  vs 345K

Q3.23

arrow
arrow

-9%

541.3K  vs 592.1K

Return on EquityShape

status-upQoQ

Q4.21

arrow
arrow

-192%

-1.92
vs -0.43

Q1.22

arrow
arrow

+232%

2.32
vs -1.92

Q2.22

arrow
arrow

+61%

0.61
vs 2.32

Q3.22

arrow
arrow

+34%

0.34
vs 0.61

Q4.22

arrow
arrow

+39%

0.39
vs 0.34

Q1.23

arrow
arrow

+16%

0.16
vs 0.39

Q2.23

arrow
arrow

+13%

0.13
vs 0.16

Q3.23

arrow
arrow

+14%

0.14
vs 0.13

Institutionnal OwnershipShape

status-up

Earnings Growth

Latest News